The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got brighter. In an initial trial, a single dose of a CRISPR gene-editing therapy ...

N2K Networks is proud to announce the return of its flagship cybersecurity leadership podcast, CISO Perspectives on the N2K CyberWire network, with veteran CISO and educator Kim Jones as the new host.

The Boston-based company said its gene-editing treatment for people with high cholesterol was well-tolerated with no serious ...

To combat one of Australia’s most troublesome species, researchers are developing hungry tadpoles that never grow up ...

The results show dose-dependent LDL-lowering and, in contrast to what was seen previously with VERVE-101, no safety issues.

A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific world. Developed from a ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...